Alltoft Jennifer Sadie received 1,774 derivative securities of Mesa Laboratories Inc. on Sep. 9, 2009. The transaction represented about 100.0% of her resulting derivative securities holding, giving investors a complete view of the position recorded after the award and its classification under transaction code A.
Key Highlights
- The transaction occurred on Sep. 9, 2009, under transaction code A.
- Alltoft Jennifer Sadie held 1,774 derivative securities after the transaction.
- The award represented about 100.0% of her resulting derivative securities holding.
Alltoft Jennifer Sadie received 1,774 derivative securities of Mesa Laboratories Inc. on Sep. 9, 2009. Alltoft Jennifer Sadie’s resulting derivative securities holding was 1,774 after the transaction.
Full Share of Resulting Derivative Holdings
The award represented about 100.0% of Alltoft Jennifer Sadie’s resulting derivative securities holding. That percentage describes the transaction’s share of her post-transaction derivative position.
FAQs
Q: What percentage of Alltoft Jennifer Sadie’s derivative holdings did the award represent?
A: The award represented about 100.0% of Alltoft Jennifer Sadie’s resulting derivative securities holding. Her recorded post-transaction holding was 1,774 derivative securities.
Q: When did the Mesa Laboratories insider transaction occur?
A: The transaction occurred on Sep. 9, 2009. Alltoft Jennifer Sadie was identified as a director of Mesa Laboratories Inc. in the transaction record.
Q: Who received the derivative securities, and when did the transaction occur?
A: Alltoft Jennifer Sadie received 1,774 derivative securities of Mesa Laboratories Inc. on Sep. 9, 2009. The transaction record identified the company as MLAB.
Q: What was Alltoft Jennifer Sadie’s resulting derivative securities holding?
A: After the transaction, Alltoft Jennifer Sadie held 1,774 derivative securities. The award represented about 100.0% of her resulting derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.